Reactive infectious mucocutaneous eruption: an increasingly encountered complication during periods of increased Mycoplasma pneumoniae transmission—a case report
Open Access
- 4 November 2025
- journal article
- case report
- Published by American Society for Microbiology in ASM Case Reports
- Vol. 1 (6)
Abstract
Background: Mycoplasma pneumoniae is a common cause of community-acquired pneumonia among children and young adults. Surveillance within the United States has identified increased levels of M. pneumoniae -mediated respiratory disease following a multi-year period of minimal detection during the COVID-19 pandemic. A wide spectrum of extrapulmonary complications can be associated with M. pneumoniae infections, including dermatological disease. Reactive infectious mucocutaneous eruption (RIME) is a constellation of immune-mediated extrapulmonary manifestations causing ulceration of multiple mucous membranes that occurs in up to 25% M . pneumoniae cases. Case Summary: An adolescent patient presenting with acute hypoxic respiratory failure and an eight-day history of conjunctivitis and oral ulcers tested positive for M. pneumoniae from a nasopharyngeal specimen and was diagnosed with RIME. A retrospective review of increased M. pneumoniae test positivity and hospitalizations at our institution was undertaken, which mirrored national trends. Conclusion: As dedicated M. pneumoniae testing may not be available in all settings, clinicians should consider a diagnosis of RIME for patients presenting with similar para- or post-infectious mucositis, even in the absence of traditional respiratory symptoms. RIME incidence is expected to increase in the setting of a higher prevalence of M. pneumoniae disease. As RIME can be associated with significant morbidity including dehydration and weight loss as well as disease recurrence, proper management of patient symptomatology is essential.Keywords
This publication has 25 references indexed in Scilit:
- Mycoplasma pneumoniae incidence, phenotype, and severity in children and adolescents in Denmark before, during, and after the COVID-19 pandemic: a nationwide multicentre population-based cohort studyThe Lancet Regional Health - Europe, 2024
- Recurrent reactive infectious mucocutaneous eruption: A retrospective cohort studyJournal of the American Academy of Dermatology, 2023
- Recurrent Mycoplasma pneumoniae–associated reactive infectious mucocutaneous eruption responsive to systemic steroids: A case seriesJAAD Case Reports, 2021
- Frequency and Clinical Presentation of Mucocutaneous Disease Due to Mycoplasma pneumoniae Infection in Children With Community-Acquired PneumoniaJAMA Dermatology, 2020
- Mucocutaneous Eruptions in Acutely Ill Pediatric Patients—Think of Mycoplasma pneumoniae (and Other Infections) FirstJAMA Dermatology, 2020
- Clinical and histologic features of Mycoplasma pneumoniae –related erythema multiforme: A single-center series of 33 cases compared with 100 cases induced by other causesJournal of the American Academy of Dermatology, 2018
- Mycoplasma pneumoniae–induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: A systematic reviewJournal of the American Academy of Dermatology, 2015
- New concepts of Mycoplasma pneumoniae infections in childrenPediatric Pulmonology, 2003
- Stevens-Johnson syndrome and Mycoplasma pneumoniae: Evidence for cutaneous infectionThe Journal of Pediatrics, 1987
- Stevens-Johnson syndrome with isolation ofMycoplasma pneumoniae from skin lesionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986